Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy
Authors
Keywords
Prostate neoplasms, Neoplasm recurrence, local, Prognosis, Vascular endothelial growth factor-A, Genotypes, Prostataneoplasien, Lokales Neoplasierezidiv, Prognose, Vaskulärer endothelialer Wachstumsfaktor A, Genotypen
Journal
STRAHLENTHERAPIE UND ONKOLOGIE
Volume 190, Issue 4, Pages 364-369
Publisher
Springer Nature
Online
2014-01-16
DOI
10.1007/s00066-013-0503-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer
- (2013) Sung Yong Oh et al. BMC CANCER
- In vitro hypoxic cytotoxicity and hypoxic radiosensitization
- (2013) M. Langenbacher et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck
- (2013) N.D. Seibold et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Vascular Endothelial Growth Factor Pathway Polymorphisms as Prognostic and Pharmacogenetic Factors in Cancer: A Systematic Review and Meta-analysis
- (2012) L. Eng et al. CLINICAL CANCER RESEARCH
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- (2012) William Kevin Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Positive association of the vascular endothelial growth factor-A +405 GG genotype and poor survival in stage I–II gastric cancer in the Northern Chinese population
- (2012) Ailin Li et al. MOLECULAR BIOLOGY REPORTS
- Association ofVEGFandKDRsingle nucleotide polymorphisms with colorectal cancer susceptibility in Koreans
- (2012) Moon Ju Jang et al. MOLECULAR CARCINOGENESIS
- Treatment selection in metastatic renal cell carcinoma: expert consensus
- (2012) Bernard Escudier et al. Nature Reviews Clinical Oncology
- Hypoxia-related molecules HIF-1α, CA9, and osteopontin
- (2012) O.P. Erpolat et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Acute versus chronic hypoxia in tumors
- (2012) C. Bayer et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
- (2011) F. Dayyani et al. JNCI-Journal of the National Cancer Institute
- Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy
- (2009) D. H. Kim et al. ANNALS OF ONCOLOGY
- Targeting Angiogenesis Driven by Vascular Endothelial Growth Factors Using Antibody-Based Therapies
- (2008) Axel Grothey et al. CANCER JOURNAL
- VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy
- (2008) H. J. Burstein et al. CLINICAL CANCER RESEARCH
- Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy
- (2008) C. Timke et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started